Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | latrophilin 2 splice variant baaae | 0.004 | 0.0421 | 0.2669 |
Echinococcus multilocularis | zinc finger protein | 0.0023 | 0.0011 | 0.0011 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0058 | 0.0866 | 0.5495 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0421 | 0.1166 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Schistosoma mansoni | serine-rich repeat protein | 0.0093 | 0.1692 | 0.4692 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.007 | 0.1144 | 0.1144 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0473 | 0.0473 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.1455 | 1 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0026 | 0.0095 | 0.0263 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0609 | 0.4183 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0058 | 0.0866 | 0.5495 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0058 | 0.0866 | 0.5951 |
Brugia malayi | Bromodomain containing protein | 0.0088 | 0.1576 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0866 | 0.5951 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0 | 0.5 |
Brugia malayi | PHD-finger family protein | 0.0029 | 0.0162 | 0.1027 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0662 | 0.4553 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0394 | 0.8965 | 0.8965 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0026 | 0.0095 | 0.0095 |
Brugia malayi | Cache domain containing protein | 0.0079 | 0.1373 | 0.8712 |
Schistosoma mansoni | bromodomain containing protein | 0.0074 | 0.1245 | 0.3452 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0042 | 0.0473 | 0.0473 |
Trichomonas vaginalis | regulator of G protein signaling 5, rgs5, putative | 0.0022 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0093 | 0.1692 | 0.4692 |
Schistosoma mansoni | zinc finger protein | 0.0023 | 0.0011 | 0.0031 |
Brugia malayi | Bromodomain containing protein | 0.0045 | 0.054 | 0.3425 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0024 | 0.0041 | 0.0282 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.0421 | 0.2891 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.007 | 0.1144 | 0.1144 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0179 | 0.3782 | 0.3782 |
Echinococcus granulosus | zinc finger protein | 0.0023 | 0.0011 | 0.0011 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0179 | 0.3782 | 0.3782 |
Entamoeba histolytica | hypothetical protein | 0.0022 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0542 | 0.3723 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0394 | 0.8965 | 0.8965 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0172 | 0.3606 | 1 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0087 | 0.1549 | 0.4297 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0041 | 0.0114 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.1373 | 0.9435 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0022 | 0 | 0.5 |
Echinococcus multilocularis | expressed protein | 0.0437 | 1 | 1 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0026 | 0.0095 | 0.0095 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.